AbstractThis study examined the relations among beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure in patients after myocardial infarction. The study was performed with the placebo group of the Multicenter Diltiazem Post-Infarction Trial. Ejection fraction data were available in 1,084 patients; of these, 557 were receiving a beta-blocker and 527 were not. In addition to ejection fraction, other correlates of left ventricular function included the presence or absence of pulmonary rales, chest X-ray film evidence of pulmonary congestion and the presence of an S3gallop.Beta-blocker use was less frequent in patients with an ejection fraction <30%, rales, an S3gallop...
AbstractOBJECTIVESThe purpose of this study was to determine whether higher left ventricular inotrop...
AbstractBackgroundBeta-blocker therapy after acute myocardial infarction (MI) improves survival. Bet...
BACKGROUND: Besides the conventional therapy for heart failure, the diuretics, cardiac glycosides an...
AbstractThis study examined the relations among beta-adrenergic blocker use, various correlates of l...
Beta-adrenergic blocking agents have been widely used in ischemic heart disease. They have achieved ...
Objectives.Our aim was to determine the percent of patients with myocardial infarction who are treat...
OBJECTIVES The purpose of this study was to determine the effect of beta-blocker therapy on outcomes...
AbstractObjectivesThis prospective study tested the impact of beta-blocker treatment on currently us...
AbstractObjectives. This study assessed whether treatment with a beta-adrenergic blocking agent in a...
BackgroundBecause most randomised trials assessing beta-blocker therapy after acute myocardial infar...
ObjectivesThe purpose of this study was to evaluate the role of heart rate reduction with beta-block...
ObjectivesThis study sought to examine the association between baseline beta-blocker (BB) dose and o...
Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acut...
AbstractBackgroundThe effectiveness of beta-blockers for preventing cardiac events has been question...
AbstractOBJECTIVESThis analysis was performed to assess whether beta-adrenergic blocking agent use i...
AbstractOBJECTIVESThe purpose of this study was to determine whether higher left ventricular inotrop...
AbstractBackgroundBeta-blocker therapy after acute myocardial infarction (MI) improves survival. Bet...
BACKGROUND: Besides the conventional therapy for heart failure, the diuretics, cardiac glycosides an...
AbstractThis study examined the relations among beta-adrenergic blocker use, various correlates of l...
Beta-adrenergic blocking agents have been widely used in ischemic heart disease. They have achieved ...
Objectives.Our aim was to determine the percent of patients with myocardial infarction who are treat...
OBJECTIVES The purpose of this study was to determine the effect of beta-blocker therapy on outcomes...
AbstractObjectivesThis prospective study tested the impact of beta-blocker treatment on currently us...
AbstractObjectives. This study assessed whether treatment with a beta-adrenergic blocking agent in a...
BackgroundBecause most randomised trials assessing beta-blocker therapy after acute myocardial infar...
ObjectivesThe purpose of this study was to evaluate the role of heart rate reduction with beta-block...
ObjectivesThis study sought to examine the association between baseline beta-blocker (BB) dose and o...
Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acut...
AbstractBackgroundThe effectiveness of beta-blockers for preventing cardiac events has been question...
AbstractOBJECTIVESThis analysis was performed to assess whether beta-adrenergic blocking agent use i...
AbstractOBJECTIVESThe purpose of this study was to determine whether higher left ventricular inotrop...
AbstractBackgroundBeta-blocker therapy after acute myocardial infarction (MI) improves survival. Bet...
BACKGROUND: Besides the conventional therapy for heart failure, the diuretics, cardiac glycosides an...